Report Company Directory

Medcom Tech S.A.

MEDEA INVERSIONES SICAV SA

Medeon Biodesign

• Ford Equity International Rating and Forecast Report by Ford Equity Research

MedEquities Realty Trust

• Ruth's Hospitality Group Inc - Company Profile and SWOT Analysis by MarketLine
• HR.UN | 4Q19 Results: Dispositions and Development Defines the Year by Raymond James
• HR.UN | 3Q19 Results: Focus on Development Grows by Raymond James
• MRT | Dropping Coverage Following Closing of Merger With Omega by Raymond James
• Raymond James Afternoon Notes by Raymond James
• REITs | 1Q2019 REIT Outlook by Raymond James
• Raymond James Afternoon Notes by Raymond James
• Raymond James Afternoon Notes by Raymond James
• OHI | Daybreak Not Broken; Reiterate Outperform Rating and $38 Target Price by Raymond James
• Raymond James Afternoon Notes by Raymond James

Medesis Pharma SA

• INVEST SECURITIES - MEDESIS : Rdvs cruciaux au T1 25, clinique, financier et juridique - NEUTRE, OC 0,8€ by Invest Securities
• INVEST SECURITIES - MEDESIS : Plan de développement soumis au financement - NEUTRE, OC 0,8€ (vs 3,3€) by Invest Securities
• INVEST SECURITIES - MEDESIS : Aucun effet indésirable à 12 mois avec Nanolithium - NEUTRE, OC 3,3€ by Invest Securities
• INVEST SECURITIES - MEDESIS : Trésorerie étendue à octobre 2024, verdict fin T3 24 - NEUTRE, OC 3,3€ by Invest Securities
• INVEST SECURITIES - MEDESIS : Fin septembre, la croisée des chemins pour MEDESIS - NEUTRE, OC 3,3€ by Invest Securities
• INVEST SECURITIES - MEDESIS : Près d'1m€ à recevoir à CT, décalage des résultats - NEUTRE, OC 3,3€ by Invest Securities
• INVEST SECURITIES - MEDESIS : Accueil très positif de la fin des OCA - NEUTRE, OC 3,3€ by Invest Securities
• Top picks Biotech : La prudence devra être de mise by Invest Securities
• Top picks Biotech : La prudence devra être de mise by Invest Securities
• INVEST SECURITIES – MEDESIS : PN stable, trésorerie faible, accord attendu à CT - NEUTRE, OC 3,3€ by Invest Securities